ORGN
Overvalued by 81% based on the discounted cash flow analysis.
Market cap | $64.67 Million |
---|---|
Enterprise Value | $31.58 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.58 |
Beta | 0.81 |
Outstanding Shares | 146,853,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -658.22 |
---|---|
PEG | -730.99 |
Price to Sales | - |
Price to Book Ratio | 0.22 |
Enterprise Value to Revenue | 1.06 |
Enterprise Value to EBIT | -0.33 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 0.34 |
Debt to Equity | 0.03 |
No data
No data